Log In
BCIQ
Print this Print this
 

PTX-9908

  Manage Alerts
Collapse Summary General Information
Company Pertinax Therapeutics Inc.
DescriptionStromal cell-derived factor-1 (SDF-1) analog
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationLiver cancer
Indication DetailsTreat liver cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/16/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today